An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines

Mostrar otras versiones (1)

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein mediates viral entry into cells expressing angiotensin-converting enzyme 2 (ACE2). The S protein engages ACE2 through its receptor-binding domain (RBD), an independently folded 197-amino-acid fragment of the 1,273-ami...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yan, He, Wenhui, Mou, Huihui, Zhang, Lizhou, Chang, Jing, Peng, Shoujiao, Ojha, Amrita, Tavora, Rubens, Parcells, Mark S., Luo, Guangxiang, Li, Wenhui, Zhong, Guocai, Choe, Hyeryun, Farzan, Michael, Quinlan, Brian D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262850/
https://www.ncbi.nlm.nih.gov/pubmed/33975938
http://dx.doi.org/10.1128/mBio.00930-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262850/
https://www.ncbi.nlm.nih.gov/pubmed/33975938
http://dx.doi.org/10.1128/mBio.00930-21

Ejemplares similares